|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
89.800 -2.400 (-2.603%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 49,156 | 697.987% | 6,160 | 6,930 |
| Cost of Sales | (5,405) | 374.123% | (1,140) | (149) |
| Gross Profit | 43,751 | 771.534% | 5,020 | 6,781 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | (25,193) | 352.623% | (5,566) | -- | |
| Share of Results of Asso. & JCEs | (238) | -60.920% | (609) | (915) | |
| Profit / (Loss) before Taxation | (395,302) | 8.464% | (364,456) | (160,396) | |
| Taxation | 0 | -- | 23 | 1 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (395,302) | 8.470% | (364,433) | (160,395) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (166) | 84.444% | (90) | (4,241) |
| Depreciation & Amortisation | 37,148 | 15.596% | 32,136 | 22,434 |
| Directors' Emoluments | -- | -- | 101,861 | 4,068 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | |
| EPS (cts) | -136.000 | -80.029% | -681.000 | -317.000 |
| DPS (cts) | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | (0.620) | -- | (4.105) | (2.771) |
| NBV per share ($) | 4.884 | -- | -- | -- |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -395,302 |
| %Change | 8.470% |
| EPS / (LPS) | RMB -1.360 |
| NBV Per Share (¥) | RMB 4.884 |